SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Fluoxetine Oral Solution, USP 20 mg/5 mL is available by prescription and should only be used under the guidance of a licensed healthcare provider to ensure safe and effective treatment.

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find out why PFE stock is a Hold.

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

Eton Pharmaceuticals announces FDA approval and upcoming commercial launch of KHINDIVI, an oral hydrocortisone solution for pediatric patients.

KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml strength designed to eliminate the need to split or crush tablets, and to offer simple and ...

Freud's theory suggests people can develop oral fixation if their needs are unmet during development. This may manifest as oral-based adult behaviors. Read more.

The FDA has accepted for review the New Drug Application for a 25 mg oral formulation of semaglutide for chronic weight management.

Read about Lockheed's move to acquire Amentum's Rapid Solutions business, which produces airborne and space ISR and tactical systems.

Merck will use Cyprumed’s oral peptide delivery platform for an undisclosed number of targets and up to $493 million biobucks on the table.

April 15, 2025 Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology.